Is It Too Late to File a GLP-1 Claim?

Marin & MurphySuper Lawyers® 2014–2024(888) 348-2735

Ozempic (GLP-1) Lawsuit — Free Case Review

Suing the Maker Is Not Suing Your Doctor

The claim is against the manufacturer — your doctor isn't the target. See if your situation fits the current criteria.

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state.

Did this happen to you — or someone you love?

Start your free case reviewTell us anyway

Answered 24/7 · Free & confidential · No fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney's fee is a percentage of the gross recovery, calculated before expenses are deducted.

(888) 348-2735

Partners

Matthew T. Marin & Stefanie A. Murphy

Super Lawyers® honorees · American Association for Justice members

Ozempic inquiries get a personal review — and an honest answer either way, free and without obligation.

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state. Do not stop, start, or change any prescribed medication because of anything on this page. Those decisions belong with your prescriber. Attorney Advertising.

It depends on which injury and which dates. NAION claims currently have no diagnosis-date cutoff in the referral criteria — that track remains open. Stomach-injury claims are screened against a criteria line requiring diagnosis before December 31, 2024; that is a screening rule, not a statute, and it can change. Separately, every state sets its own filing deadline. The only way to know your position is to have your dates reviewed.

Two different clocks, and people confuse them

There are two timing questions, and they come from different places.

The first is a screening criterion — the date rules determining which claims are currently being reviewed. Criteria reflect where the science and the court rulings sit today and are revised as things develop. A criterion is not law.

The second is a statute of limitations — each state’s deadline for filing at all. That one is law, it is not negotiable, and it varies by state and by how that state treats an injury a person did not immediately connect to a medication. You can be inside one and outside the other, which is why a review of your dates is worth more than a general answer.

The NAION track: open, with no diagnosis-date cutoff

For NAION — non-arteritic anterior ischemic optic neuropathy — the current criteria state no outer date limit on when the diagnosis was made; a diagnosis made while taking the medication or after stopping can qualify. They do require an actual NAION diagnosis rather than a suspected one, some degree of permanent vision impairment, and brand-name Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, or Zepbound.

The litigation is also young: MDL 3163 was created December 15, 2025 and had 216 cases pending as of the September 2026 JPML report, against 4,022 on the stomach-injury side. That does not mean state deadlines are suspended for NAION. They are not.

The stomach-injury track: a December 31, 2024 criteria line

For gastroparesis and gastric obstruction claims, the current criteria require diagnosis before December 31, 2024. Alongside that: diagnosed while taking the medication or within about 30 days of stopping; confirmed by a gastric emptying study or, for obstruction, other objective testing; a related ER visit or hospital admission; brand-name Ozempic, Wegovy, or Rybelsus; and an age limit of 75 at intake.

Be clear about what that December 2024 line is. It reflects the current shape of the litigation. It is not a statute, no court imposed it, and it is subject to change. If your diagnosis landed in early 2025, or you are unsure of the month, tell us rather than assuming. Near-miss dates go to a closer review.

State filing deadlines: the part that genuinely varies

Every state limits how long a person has to bring a personal-injury claim. Some allow several years; a small number allow only one. Some apply a “discovery rule,” under which the clock may start when a person knew or should have known an injury was connected to a product rather than on the date of injury; others do not.

Which rule applies depends on your state of residence, where you were treated, and the dates in your records — an answer a page cannot give you and a free review can.

The dates worth writing down before you call

• Start and stop month and year for each GLP-1 you have taken, by brand.
• Month and year of diagnosis and the diagnosing physician or practice.
• Month and year of any ER visit or hospital admission.
• Whether a gastric emptying study was performed, and roughly when. “I’m not sure what tests I had” is a common and acceptable answer.
• When you first connected the injury to the medication. In discovery-rule states this date can matter.
• Your state of residence at the time of injury and today, if they differ.

What we will not do

We will not tell you a window is about to close to get you to call faster. There is no settlement to be late for and no countdown. No GLP-1 case has settled and none has been tried. The stomach-injury proceeding is now in a Rule 702 hearing on expert evidence, September 14 through 18, 2026, and in August 2025 that court ruled gastroparesis claims must rest on a properly performed gastric emptying study. The NAION proceeding has issued no merits rulings.

Common questions

Common questions: can you sue?, it’s not about your doctor, still taking Ozempic?, still on a GLP-1, stopped taking it, switched drugs, calling for a parent, and how compensation works.